DK0695301T3 - Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne - Google Patents
Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræneInfo
- Publication number
- DK0695301T3 DK0695301T3 DK94913573.5T DK94913573T DK0695301T3 DK 0695301 T3 DK0695301 T3 DK 0695301T3 DK 94913573 T DK94913573 T DK 94913573T DK 0695301 T3 DK0695301 T3 DK 0695301T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- migraine
- agonists
- indole derivatives
- date oct
- Prior art date
Links
- 208000019695 Migraine disease Diseases 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title abstract 2
- 206010027599 migraine Diseases 0.000 title abstract 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
- -1 3,5-disubstituted indole compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308360A GB9308360D0 (en) | 1993-04-22 | 1993-04-22 | Indoles |
| GB939324433A GB9324433D0 (en) | 1993-11-27 | 1993-11-27 | Indoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0695301T3 true DK0695301T3 (da) | 1996-12-09 |
Family
ID=26302791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94913573.5T DK0695301T3 (da) | 1993-04-22 | 1994-04-11 | Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5607960A (de) |
| EP (1) | EP0695301B1 (de) |
| JP (1) | JP2802169B2 (de) |
| KR (1) | KR960701865A (de) |
| CN (1) | CN1121348A (de) |
| AT (1) | ATE144773T1 (de) |
| AU (1) | AU6567094A (de) |
| BR (1) | BR9406481A (de) |
| CA (1) | CA2157397C (de) |
| CZ (1) | CZ274595A3 (de) |
| DE (1) | DE69400824T2 (de) |
| DK (1) | DK0695301T3 (de) |
| ES (1) | ES2094653T3 (de) |
| FI (1) | FI954944A0 (de) |
| GR (1) | GR3021804T3 (de) |
| HU (1) | HUT73807A (de) |
| IL (1) | IL109337A0 (de) |
| NO (1) | NO954168D0 (de) |
| NZ (1) | NZ265269A (de) |
| PL (1) | PL311204A1 (de) |
| WO (1) | WO1994024127A1 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| CA2169179C (en) * | 1993-08-31 | 2000-02-29 | John E. Macor | 5-arylindole derivatives |
| GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9420503D0 (en) * | 1994-10-11 | 1994-11-23 | Pfizer Ltd | Therapeutic agents |
| GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
| AU702322B2 (en) * | 1995-03-20 | 1999-02-18 | Eli Lilly And Company | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
| AU4074897A (en) * | 1996-09-18 | 1998-04-14 | Eli Lilly And Company | A method for the prevention of migraine |
| ES2208955T3 (es) * | 1996-11-26 | 2004-06-16 | Nps Allelix Corp. | Compuestos 5-ciclo-indolicos como ligandos del receptor 5-ht1d. |
| US5998462A (en) * | 1996-12-16 | 1999-12-07 | Allelix Biopharmaceuticals Inc. | 5-alkyl indole compounds |
| US5856510A (en) * | 1996-12-16 | 1999-01-05 | Allelix Biopharmaceuticals Inc. | 5-alkenyl and 5-alkynyl indole compounds |
| GB9705035D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| EP0875513A1 (de) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituierte heteroaromatische 5-HT1F Agoniste |
| JP2001512727A (ja) | 1997-08-09 | 2001-08-28 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ−１受容体のリガンドとしてのニ環式化合物 |
| US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
| US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
| US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| WO2000000490A2 (en) * | 1998-06-26 | 2000-01-06 | Eli Lilly And Company | 5-ht1f agonists |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| HUP0302820A3 (en) * | 2000-07-21 | 2006-04-28 | Lundbeck & Co As H | Indole derivatives useful for the treatment of cns disorders and pharmaceutical compositions containing them |
| US6489512B1 (en) * | 2002-06-21 | 2002-12-03 | Rhodia Chirex Inc. | Method for making aryl hydrazines and substituted indoles |
| BR0317126A (pt) * | 2002-12-10 | 2005-10-25 | Merck Patent Gmbh | Derivados de indol e o uso dos mesmos como ligantes de 5-ht |
| CN1729174B (zh) * | 2002-12-20 | 2015-10-21 | 西巴特殊化学品控股有限公司 | 胺的合成以及用于合成胺的中间体 |
| ES2380827T3 (es) * | 2002-12-26 | 2012-05-18 | Pozen, Inc. | Formas de dosificación con múltiples capas que contienen naproxeno y triptanes |
| AU2004247076A1 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and NSAIDs |
| US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
| WO2005066157A1 (en) * | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
| GB0807772D0 (en) * | 2008-04-29 | 2008-06-04 | Lectus Therapeutics Ltd | Calcium ion modulators and uses thereof |
| FR2953720B1 (fr) * | 2009-12-11 | 2012-05-11 | Oreal | Utilisation de derives de benzyloxy-ethylamines comme conservateur, |
| CN104557957B (zh) * | 2013-10-09 | 2017-04-19 | 华东师范大学 | 螺‑氧化吲哚环氧乙烷衍生物的合成方法 |
| CN115380028A (zh) * | 2020-02-04 | 2022-11-22 | 明德赛特制药公司 | 用于治疗cns病症的作为血清素能致幻剂的3-吡咯烷-吲哚衍生物 |
| AU2024298630A1 (en) * | 2023-07-24 | 2026-02-05 | Innovstone Therapeutics Limited | 5-ht2a receptor agonist, and preparation method therefor and use thereof |
| WO2025104491A1 (en) | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8530507D0 (en) * | 1985-12-11 | 1986-01-22 | Glaxo Group Plc | Chemical compounds |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| CA2091562C (en) * | 1990-10-15 | 2001-03-27 | John Eugene Macor | Indole derivatives useful in psychotherapeutics |
-
1994
- 1994-04-11 AU AU65670/94A patent/AU6567094A/en not_active Abandoned
- 1994-04-11 BR BR9406481A patent/BR9406481A/pt not_active Application Discontinuation
- 1994-04-11 DE DE69400824T patent/DE69400824T2/de not_active Expired - Fee Related
- 1994-04-11 CZ CZ952745A patent/CZ274595A3/cs unknown
- 1994-04-11 WO PCT/EP1994/001121 patent/WO1994024127A1/en not_active Ceased
- 1994-04-11 DK DK94913573.5T patent/DK0695301T3/da active
- 1994-04-11 US US08/532,573 patent/US5607960A/en not_active Expired - Fee Related
- 1994-04-11 NZ NZ265269A patent/NZ265269A/en unknown
- 1994-04-11 KR KR1019950704623A patent/KR960701865A/ko not_active Ceased
- 1994-04-11 JP JP6522726A patent/JP2802169B2/ja not_active Expired - Fee Related
- 1994-04-11 ES ES94913573T patent/ES2094653T3/es not_active Expired - Lifetime
- 1994-04-11 CN CN94191850A patent/CN1121348A/zh active Pending
- 1994-04-11 EP EP94913573A patent/EP0695301B1/de not_active Expired - Lifetime
- 1994-04-11 PL PL94311204A patent/PL311204A1/xx unknown
- 1994-04-11 AT AT94913573T patent/ATE144773T1/de not_active IP Right Cessation
- 1994-04-11 CA CA002157397A patent/CA2157397C/en not_active Expired - Fee Related
- 1994-04-11 HU HU9501920A patent/HUT73807A/hu unknown
- 1994-04-18 IL IL10933794A patent/IL109337A0/xx unknown
-
1995
- 1995-10-17 FI FI954944A patent/FI954944A0/fi not_active Application Discontinuation
- 1995-10-19 NO NO954168A patent/NO954168D0/no unknown
-
1996
- 1996-11-28 GR GR960403195T patent/GR3021804T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2802169B2 (ja) | 1998-09-24 |
| GR3021804T3 (en) | 1997-02-28 |
| NZ265269A (en) | 1996-09-25 |
| EP0695301A1 (de) | 1996-02-07 |
| BR9406481A (pt) | 1996-01-09 |
| FI954944A7 (fi) | 1995-10-17 |
| EP0695301B1 (de) | 1996-10-30 |
| PL311204A1 (en) | 1996-02-05 |
| FI954944A0 (fi) | 1995-10-17 |
| IL109337A0 (en) | 1994-07-31 |
| NO954168L (no) | 1995-10-19 |
| CN1121348A (zh) | 1996-04-24 |
| HUT73807A (en) | 1996-09-30 |
| KR960701865A (ko) | 1996-03-28 |
| CA2157397A1 (en) | 1994-10-27 |
| DE69400824D1 (de) | 1996-12-05 |
| NO954168D0 (no) | 1995-10-19 |
| WO1994024127A1 (en) | 1994-10-27 |
| JPH08507083A (ja) | 1996-07-30 |
| ES2094653T3 (es) | 1997-01-16 |
| CZ274595A3 (en) | 1996-03-13 |
| US5607960A (en) | 1997-03-04 |
| HU9501920D0 (en) | 1995-09-28 |
| DE69400824T2 (de) | 1997-03-13 |
| CA2157397C (en) | 1999-07-06 |
| AU6567094A (en) | 1994-11-08 |
| ATE144773T1 (de) | 1996-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954168D0 (no) | Indolderivater som 5-HT1-lignende agonister for anvendelse mot migrene | |
| DK0544819T3 (da) | Indolderivater, som inhiberer leukotrienbiosyntese | |
| FI970148A0 (fi) | Heterosyklisten yhdisteiden käyttö dopamiini-D3-ligandeina | |
| NO960365D0 (no) | Perhydroisoindolderivater som substans-P-antagonister | |
| ES2121193T3 (es) | Derivados de bencimidazoles. | |
| ES2138364T3 (es) | Procedimiento para el almacenamiento reversible de hidrogeno. | |
| TR200000782T2 (tr) | Resorsinol türevleri. | |
| FI970147A0 (fi) | Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina | |
| ATE291917T1 (de) | Topisch anzuwendende ketoconazol enthaltende emulsionen | |
| IL152097A0 (en) | Use of pyrazole derivatives for treating infertility | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| ATE253930T1 (de) | Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)- aktivierungsweges | |
| DE69819742D1 (de) | Indolderivate als 5-ht1b und 5-ht1d agonisten | |
| NO20002408L (no) | 5-HT1F antagonister | |
| DE59511073D1 (de) | Agonisten und antagonisten der nicotinergen acetylcholinrezeptoren von insekten als endoparasitizide | |
| ATE197453T1 (de) | Imidazol-, triazol- und tetrazolderivate | |
| DK0943030T3 (da) | Fremgangsmåde til reduktion af svovl- og kypefarvestoffer | |
| DK1163248T3 (da) | 1,5-anhydro-D-fructose substitueret med en hydrofob gruppe til brug som en antioxidant og/eller emulgator | |
| PT1115404E (pt) | Utilizacao de antagonistas prostanoides para o tratamento de cefaleias primarias | |
| NO991961L (no) | FremgangsmÕte for Õ regenerere antrakinonderivater under hydrogenperoksyd-synteseprosessen | |
| YU29496A (sh) | So pirolidinil metil indola | |
| DK0923549T3 (da) | Methansulfonatsalt af et arylpiperazin afledt af tryptamin og solvater deraf til farmaceutisk anvendelse | |
| DE69528288D1 (de) | Indolderivate zur behandlung von migräne |